1-7 of 7
Jackie M. Walling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Alice S. Mims, Melhem Solh, Jennifer N. Saultz, Uma Borate, Naveen Pemmaraju, Gautam Borthakur, Gail J. Roboz, Ben Powell, Bernice Matusow, Jason Halladay, Shireen Vali, Chelsea L. Hope, Madan G. Kundu, Ching Hsu, Paul Watkins, Chao Zhang, Jackie M. Walling, Athanasios C. Tsiatis, Amy E. DeZern
Journal: Blood
Blood (2021) 138 (Supplement 1): 3420.
https://doi.org/10.1182/blood-2021-152040
Published: 2021
Journal Articles

Phase 1b Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Alice S. Mims, MD, Melhem Solh, MD, Uma Borate, Naveen Pemmaraju, MD, Gautam Borthakur, MD, Gail J. Roboz, MD, Ben Powell, PhD, Paul Severson, PhD, Bernice Matusow, Jason Halladay, PhD, Ching Hsu, PhD, Paul Watkins, Chao Zhang, PhD, Jackie M. Walling, PhD MD, Athanasios C. Tsiatis, MD, Amy E. DeZern, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-140138
Published: 2020
Journal Articles

Dose Escalation Study of BET Inhibitor PLX2853 in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Naveen Pemmaraju, MD, Uma Borate, MD, Melhem Solh, MD, Gautam M. Borthakur, MD, Amy E. DeZern, MD, Chao Zhang, PhD, Ben Powell, PhD, Paul Severson, Kerry Inokuchi, Bernice Matusow, Jason Halladay, Ching Hsu, PhD, Paul Watkins, Jackie M. Walling, PhD MD, Athanasios C. Tsiatis, MD, Alice S. Mims, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1391.
https://doi.org/10.1182/blood-2019-127497
Published: 2019
Journal Articles

KB004, a Novel Non-Fucosylated Humaneered® Antibody, Targeting EphA3, Is Active and Well Tolerated in a Phase I/II Study of Advanced Hematologic Malignancies

Ronan T Swords, MD PhD FRCPI, FRCPath, Andrew H Wei, MBBS, PhD, Simon Durrant, MBBS, MRCS, LRCP, FRCP, FRCPat, Anjali S. Advani, MD, Mark S Hertzberg, MBBS PhDFRACP FRCPA, Ian D Lewis, MBBS, PhD, Peter L. Greenberg, MD PhD, Jorge E. Cortes, MD, Geoff T Yarranton, PhD, Jackie M. Walling, MBChB, PhD, Jeffrey E. Lancet, MD
Journal: Blood
Blood (2014) 124 (21): 3756.
https://doi.org/10.1182/blood.V124.21.3756.3756
Published: 2014
Journal Articles

An IHC Screen For EphA3 Positive FFPE Tumors

Darren Locke, PhD, Steven Bernstein, PhD, Frank Lynch, PhD, Koushan Siami-Namini, MD, FCAP, Jackie M. Walling, MBChB, PhD, Thomas Yonker, Geoffrey Yarranton, PhD
Journal: Blood
Blood (2013) 122 (21): 4965.
https://doi.org/10.1182/blood.V122.21.4965.4965
Published: 2013
Journal Articles

Analysis Of EphA3 Expression In Hematologic Malignancies By Quantitative PCR

John Woronicz, PhD, Jorge E. Cortes, MD, Jeffrey L. Jorgensen, MD, PhD, Hagop M Kantarjian, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Pramoda Challagundla, Jairo Matthews, Jennifer Ho, Jackie M. Walling, MBChB, PhD, Geoffrey Yarranton, PhD, Naveen Pemmaraju, MD
Journal: Blood
Blood (2013) 122 (21): 4981.
https://doi.org/10.1182/blood.V122.21.4981.4981
Published: 2013
Journal Articles

A Phase I Study Of KB004, a Novel Non-Fucosylated humaneered® Antibody, Targeted Against The Receptor Tyrosine Kinase EphA3, In Advanced Hematologic Malignancies

Jeffrey E Lancet, MD, Andrew H Wei, MBBS, PhD, Simon TS Durrant, Mark S. Hertzberg, MBBS, PhD, FRACP, FRCPA, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Ian D Lewis, MB, BS, PhD, Brian Jonas, MD, PhD, Jorge E. Cortes, MD, Geoffrey Yarranton, PhD, Jackie M. Walling, MBChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3838.
https://doi.org/10.1182/blood.V122.21.3838.3838
Published: 2013